Transasia Bio-Medicals in Rs. 50 crore expansion of its Sikkim manufacturing plant
Transasia Bio-Medicals' Sikkim manufacturing plant will be the largest Indian plant for the firm. It would also be Northeast’s first diagnostics manufacturing facility
Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd.
Transasia Bio-Medicals Ltd., India’s leading in-vitro diagnostics company, today announced a Rs. 50 crore investment in the expansion of its manufacturing facility in Sikkim. The largest of its India manufacturing plants, Sikkim is the fourth one after Mumbai, Daman and Baddi. Also, the first ever diagnostics manufacturing facility in Northeast, the expanded facility will significantly enhance Transasia’s capacity to cater to the growing Indian and overseas market demands. Spread over 2 acres, the state of the art facility can produce 6000+ instruments monthly including the complete range of semi-automated analyzers.
Announcing the new facility, Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd., said, “Sikkim is fast becoming a major hub for healthcare manufacturing with 14 major players already there. Transasia’s new facility will further reinforce this besides providing employment to local youth who otherwise would need to move out of the state for such quality opportunities. With this addition of capacity, we are well placed to deliver to the demand arising from continued growth posted by the company both in Indian and overseas markets.”
Limited access to quality medical infrastructure, including skilled manpower and technologies have been the pain points of over 70% of Indians who live in smaller towns and rural areas. Transasia addresses this through its competitive pricing, which makes diagnostics affordable besides having a sales & service network present nationwide. ‘Transasia on the Move’, a first in the Indian IVD Industry, is a specially designed mobile lounge to demonstrate its’ products and technology at the door steps of healthcare professionals in towns and small villages across India. 2500+ clinicians have viewed cutting edge technologies in a short span of 60 days.